<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13D" xmlns:com="http://www.sec.gov/edgar/common">
  <schemaVersion>X0202</schemaVersion>
<headerData>
    <submissionType>SCHEDULE 13D/A</submissionType>
    <previousAccessionNumber>0002111050-26-000001</previousAccessionNumber>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0002111050</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>1</amendmentNo>
      <securitiesClassTitle>Common Stock, par value $0.001 per share</securitiesClassTitle>
      <dateOfEvent>01/14/2026</dateOfEvent>
      <previouslyFiledFlag>false</previouslyFiledFlag>
      <issuerInfo>
        <issuerCIK>0001326706</issuerCIK>
        <issuerCusips>
          <issuerCusipNumber>63008J884</issuerCusipNumber>
        </issuerCusips>
        <issuerName>ENvue Medical, Inc.</issuerName>
        <address>
          <com:street1>969 PRUITT AVE,</com:street1>
          <com:street2>969 PRUITT AVE,</com:street2>
          <com:city>TYLER</com:city>
          <com:stateOrCountry>TX</com:stateOrCountry>
          <com:zipCode>77569</com:zipCode>
        </address>
      </issuerInfo>
      <authorizedPersons>
        <notificationInfo>
          <personName>Christian Glibert</personName>
          <personPhoneNum>740-507-7228</personPhoneNum>
          <personAddress>
            <com:street1>4001 Green Heron Spring Drive</com:street1>
            <com:city>Carpinteria</com:city>
            <com:stateOrCountry>CA</com:stateOrCountry>
            <com:zipCode>93013</com:zipCode>
          </personAddress>
        </notificationInfo>
      </authorizedPersons>
    </coverPageHeader>
    <reportingPersons>
      <reportingPersonInfo>
        <reportingPersonCIK>0002111050</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Glibert Christian Michael</reportingPersonName>
        <legalProceedings>N</legalProceedings>
        <aggregateAmountOwned>240000.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>6.5</percentOfClass>
        <typeOfReportingPerson>IN</typeOfReportingPerson>
      </reportingPersonInfo>
    </reportingPersons>
    <items1To7>
      <item1>
        <securityTitle>Common Stock, par value $0.001 per share</securityTitle>
        <issuerName>ENvue Medical, Inc.</issuerName>
        <issuerPrincipalAddress>
          <com:street1>969 PRUITT AVE,</com:street1>
          <com:street2>969 PRUITT AVE,</com:street2>
          <com:city>TYLER</com:city>
          <com:stateOrCountry>TX</com:stateOrCountry>
          <com:zipCode>77569</com:zipCode>
        </issuerPrincipalAddress>
      </item1>
      <item4>
        <transactionPurpose>This Amendment No. 1 to Schedule 13D is being filed to report a material change in the Reporting Person's percentage of beneficial ownership of the Issuer's Common Stock. Since the filing of the initial Schedule 13D on February 11, 2026, the Issuer's total shares outstanding increased from 1,088,192 to 3,700,908, as reported in the Issuer's Annual Report on Form 10-K filed on April 15, 2026. This increase in outstanding shares resulted in the dilution of the Reporting Person's beneficial ownership from approximately 22.1 percent to approximately 6.5 percent.

The Reporting Person has not acquired or disposed of any shares of Common Stock since the initial filing. The Reporting Person continues to hold the shares for investment purposes and may, from time to time, purchase additional shares or dispose of existing shares in the open market or in private transactions, depending on market conditions and other factors.</transactionPurpose>
      </item4>
      <item5>
        <percentageOfClassSecurities>240,000 shares which is 6.5% of shares</percentageOfClassSecurities>
        <numberOfShares>Sole power to vote: 240,000

Shared power to vote: 0

Sole power to dispose: 240,000

Shared power to dispose: 0</numberOfShares>
        <transactionDesc>none
</transactionDesc>
        <listOfShareholders>not applicable</listOfShareholders>
      </item5>
      <item6>
        <contractDescription>The information set forth in Item 6 of the initial Schedule 13D is incorporated herein by reference. There have been no material changes to the contracts or arrangements previously reported.</contractDescription>
      </item6>
    </items1To7>
    <signatureInfo>
      <signaturePerson>
        <signatureReportingPerson>Glibert Christian Michael</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Christian Michael Glibert</signature>
          <title>Christian Michael Glibert / Individual</title>
          <date>04/17/2026</date>
        </signatureDetails>
      </signaturePerson>
    </signatureInfo>
  </formData>
</edgarSubmission>
